Gut Fermentation and Reflux: The Direct Evidence Linking Your Microbiome to TLESR

man suffering from reflux

Written by Elias Darido, MD, FACS

By Elias F. Darido, MD, FACS
Foregut & GERD Surgeon | Houston Heartburn and Reflux Center
Fellowship-trained in foregut surgery, University of North Carolina at Chapel Hill
Published: October 2026 | Last Reviewed: October 2026

Every patient who comes to see me for reflux eventually asks some version of the same question: why does this keep happening? The standard answer focuses on the lower esophageal sphincter, either its resting tone is too low or a hiatal hernia has pulled it out of position. That’s true, but it’s incomplete. The actual mechanism behind the great majority of reflux episodes, in patients with GERD and in people who never develop it, is something called a transient lower esophageal sphincter relaxation, or TLESR. And there is now direct physiologic evidence that what’s fermenting in your colon can turn up the frequency of that exact reflex.

TLESR Is the Real Driver of Reflux, Not Just a Weak Sphincter

TLESR is a spontaneous opening of the LES that happens without a swallow. It’s a normal, protective reflex: when the stomach distends after a meal, vagal afferents in the proximal stomach signal the brainstem, the nucleus tractus solitarius and dorsal motor nucleus of the vagus, which signals back down to relax the sphincter and vent swallowed air or excess pressure. Every person does this. What separates a GERD patient from someone without reflux isn’t necessarily how often TLESR happens, but what comes up through the sphincter when it does, and how well the esophagus clears it afterward.

This matters because it reframes the disease. A weak or anatomically disrupted LES, from a hiatal hernia, matters enormously and is exactly what a Nissen fundoplication is built to correct. But TLESR itself is a vagally mediated reflex triggered by proximal gastric distention. It is, at its core, a nervous system event. And that’s what makes the direct evidence on gut fermentation worth taking seriously.

The Direct Evidence: Colonic Fermentation Increases TLESR Frequency

This isn’t a genetic association or a theoretical bridge. Piche and colleagues demonstrated it directly in GERD patients: stimulating colonic fermentation with a fermentable carbohydrate (fructo-oligosaccharides) significantly increased the rate of postprandial TLESRs. The mechanism runs through the gut, not the esophagus. Unabsorbed carbohydrate reaching the cecum is fermented by colonic bacteria into short-chain fatty acids and hydrogen. In earlier healthy-volunteer work, colonic infusion of these fermentation products caused dose-dependent relaxation of the proximal stomach, and it’s that same fundic relaxation, the identical distension-mediated trigger behind ordinary TLESR, that drives the increase.

The likely messenger is GLP-1. In the GERD patients studied, GLP-1 rose sharply after the fermentable carbohydrate load, and GLP-1 is known to slow gastric emptying and promote fundic relaxation. CCK didn’t appear to play a role, and hydrogen gas itself wasn’t the direct trigger. In other words, this is a humoral gut-to-stomach signal, not swallowed air and not a local esophageal effect. A distal-gut fermentation event is turning up a reflex that opens the valve at the top of the stomach.

A Second, Separate Pathway: Dysbiosis and LES Tone

There’s also a separate line of evidence, distinct from TLESR frequency, linking dysbiosis to reflux through altered baseline LES tone rather than the TLESR reflex itself. GERD, Barrett’s esophagus, and esophageal adenocarcinoma have all been associated with a shift away from Streptococcus-dominant esophageal flora toward Gram-negative organisms, and lipopolysaccharide from those organisms has been shown to relax the LES and delay gastric emptying. Reviews of nonerosive reflux disease have separately linked microbiome alterations to impaired esophageal motor function generally. This is a real mechanism, but it’s a different one from the fermentation-TLESR pathway above, and it’s measured in LES pressure and motility findings rather than TLESR counts.

Where This Overlaps With What I Already Look For

This connects directly to something I already screen for in my own practice. I’ve written previously about small intestinal bacterial overgrowth as an underdiagnosed driver of persistent bloating after fundoplication, present in roughly half of patients with that complaint and specifically treatable with rifaximin. That SIBO pathway works through reduced basal LES pressure, a different mechanism than the colonic-fermentation-to-TLESR pathway described above, but both point the same direction: gut microbial activity, not just anatomy, is shaping how much reflux a given patient experiences.

What the Evidence Doesn’t Yet Show

I want to be precise about the limits here, because they matter. Quigley’s editorial on this literature frames the open question well, asking whether “the tail can wag the dog,” meaning whether hindgut fermentation is really driving foregut reflux physiology, and points out that the operative site may be the colon rather than the small intestine, and that the direction of causation between dysbiosis and reflux remains unresolved. The Piche data are also, so far, specific to an experimentally administered fermentable carbohydrate load. They establish that colonic fermentation can increase TLESR frequency; they don’t yet tell us how much naturally occurring dysbiosis, as opposed to a deliberate fermentable-fiber challenge, moves the same needle in an individual patient. Outside of that fermentation model, most of the microbiome-LES literature reports pressure changes, inflammatory markers, or symptom associations, not manometrically measured TLESR counts. Pairing high-resolution manometry and pH-impedance testing, which I perform myself on every reflux patient, with microbiome and SCFA profiling in the same patients is the natural next step to see how much this pathway explains in everyday, non-experimental dysbiosis.

Key Clinical Points

  • TLESR, not simply a weak LES, is the dominant mechanism behind both physiologic and pathologic reflux, triggered by distention of the proximal stomach sensed through vagal afferents.
  • Direct clinical evidence (Piche et al.) shows that stimulating colonic fermentation with a fermentable carbohydrate significantly increases postprandial TLESR frequency in GERD patients, likely mediated by GLP-1-driven fundic relaxation.
  • A separate pathway links a Gram-negative/LPS shift in dysbiosis to reduced LES tone and delayed gastric emptying, distinct from the TLESR-frequency pathway.
  • SIBO is a related but distinct mechanism, acting through reduced basal LES pressure rather than TLESR frequency, and is treatable with rifaximin.
  • Open questions remain: the direction of causation between dysbiosis and GERD, whether colonic or small intestinal fermentation matters more, and how naturally occurring dysbiosis compares to an experimental fermentable-fiber challenge.
If you’ve been told your reflux is simply the result of a weak valve or a hernia, that’s still true and still the primary target of treatment. But it may not be the whole story. I’d encourage anyone with reflux that seems disproportionate to their anatomy to come in for a full diagnostic workup at Houston Heartburn and Reflux Center, where I perform every study myself and can help you understand what’s actually driving your symptoms.

 

Elias Darido, MD, FACS | Houston Heartburn and Reflux Center

 

References:

  1. Piche T, des Varannes SB, Sacher-Huvelin S, et al. Colonic Fermentation Influences Lower Esophageal Sphincter Function in Gastroesophageal Reflux Disease. Gastroenterology. 2003.
  2. Chaudhry N, Eriksson SE, Sarici IS, et al. Clinical utility of small intestinal bacterial overgrowth (SIBO) testing in guiding management of gas-bloat symptoms after antireflux surgery. Surgical Endoscopy. 2025.
  3. Tack J, Pandolfino JE. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018. Review.
  4. Mittal R, Vaezi MF. Esophageal Motility Disorders and Gastroesophageal Reflux Disease. The New England Journal of Medicine. 2020. Review.
  5. Hasan A, Hasan LK, Schnabl B, Greytak M, Yadlapati R. Microbiome of the Aerodigestive Tract in Health and Esophageal Disease. Digestive Diseases and Sciences. 2021. Review.
  6. Corning B, Copland AP, Frye JW. The Esophageal Microbiome in Health and Disease. Current Gastroenterology Reports. 2018. Review.
  7. Grover M, Barbara G, Chey W, et al. The Intestinal Microenvironment and Disorders of Gut-Brain Interaction. Gastroenterology. 2026. Review.
  8. Guan Y, Cheng H, Zhang N, et al. The Role of the Esophageal and Intestinal Microbiome in Gastroesophageal Reflux Disease: Past, Present, and Future. Frontiers in Immunology. 2025. Review.
  9. Quigley EMM. Impacts of Intestinal Fermentation on Gastroesophageal Reflux Disease: Can the Tail Wag the Dog? Diseases of the Esophagus. 2025. Opinion.
  10. Wang K, Wang S, Chen Y, Lu X, Wang D, Zhang Y, Pan W, Zhou C, Zou D. Causal relationship between gut microbiota and risk of gastroesophageal reflux disease: a genetic correlation and bidirectional Mendelian randomization study. Frontiers in Immunology. 2024;15:1327503.
  11. Physiology, Lower Esophageal Sphincter. StatPearls. 2023.
  12. Boeckxstaens GE. Inhibition of Transient Lower Esophageal Sphincter Relaxation in GERD: Will Lesogaberan Advance the Field? Gastroenterology. 2010.
  13. Bai L, et al. Vagal interoception of microbial metabolites from the small intestinal lumen. bioRxiv / iScience. 2024.
  14. Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology. 2020.